− CLIMATE — Artificial intelligence is often associated with ludicrous amounts of electricity, and therefore planet-heati…+ EDUCATION — While many schools in England have banned smartphones, in Estonia – regarded as the new European education po…− EDUCATION — In a Cambridge classroom, Joseph, 10, trained his AI model to discern between drawings of apples and drawings…− EDUCATION — OpenAI CEO Sam Altman recently told a US podcast that if he was graduating today, “I would feel like the luck…− EDUCATION — I disagree with the decision of lecturers to use artificial intelligence to create teaching materials (‘We co…− BUSINESS — Americans are growing worried about what artificial intelligence portends for their futures. Eight in 10 Amer…− BUSINESS — Accenture has reportedly begun calling its near 800,000 employees “reinventors”, as the consultancy tries to…− LABOR — US workers overwhelmingly support pro-worker policies on artificial intelligence (AI) and view labor unions a…
TruaceTracing the truth around AISunday, July 12, 2026
Subscribe
TRV-2026-0041Version 1 · Certified

Written 2026-07-12 20:50:17 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0041
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-07-12T20:50:17.695163Z
status: published
lens: p_space
sector: health
headline: Reveal linq: FDA malfunction report involving AI
dek: The FDA received a malfunction report involving Reveal linq, made by Medtronic europe sarl. It was reported that the implantable cardiac monitor (icm) experienced false pause episodes due to undersensing. it was reported that representative stated the customer is concerned that the artificial intelligence (ai) algorithm adjudicated some pause episodes as false when they determined to be true. the icm remains in the patient. no patient complications have been reported as a result of this event.
gain_reading: (none)
problem_reading: An FDA adverse-event report linked Reveal linq to an AI-related malfunction; the report requires investigation and does not by itself establish causality.
limitation: FDA adverse-event reports can be incomplete, duplicated, or unverified and do not establish that a device caused the reported outcome.
tag: Evidence-backed problem
key_points: Device: Reveal linq; manufacturer: Medtronic europe sarl. | FDA report type: Malfunction. | An adverse-event report is a safety signal, not proof that the device caused the event.
rundown: It was reported that the implantable cardiac monitor (icm) experienced false pause episodes due to undersensing. it was reported that representative stated the customer is concerned that the artificial intelligence (ai) algorithm adjudicated some pause episodes as false when they determined to be true. the icm remains in the patient. no patient complications have been reported as a result of this event.

The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate.
sources:
- government | FDA MAUDE report 24467241 | https://api.fda.gov/device/event.json?search=mdr_report_key%3A%2224467241%22&sort=date_received%3Adesc&limit=1 | 2026-02-27
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
7682fc076a07bbab9015928654d480b5fce3dd5ddcef27833776f6158b30a753
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0041 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.